Thomson Medical Group Ltd. ( (SG:A50) ) has issued an announcement.
Thomson Medical Group Ltd. has announced the launch and pricing of S$25,000,000 in aggregate principal amount of 4.65% notes due 2029, which will be consolidated with an existing series of notes issued in 2024. This issuance is part of the company’s S$1,000,000,000 Multicurrency Debt Issuance Programme, with The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch, acting as the sole dealer. The issuance is expected to strengthen the company’s financial position and support its ongoing operations and strategic initiatives, potentially impacting its market standing and stakeholder interests.
More about Thomson Medical Group Ltd.
Thomson Medical Group Ltd. is a healthcare company based in Singapore, primarily engaged in providing medical and healthcare services. The company focuses on offering a range of healthcare solutions, including specialist services, hospital operations, and fertility treatments, catering to both local and regional markets.
Average Trading Volume: 2,153
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €830M
Learn more about A50 stock on TipRanks’ Stock Analysis page.